Use of botulinum toxin type A to improve treatment of facial wounds: A prospective randomised study

Makram Ziade1, Sophie Domergue1, Dominique Batifol1, Riad Jreige2, Mustapha Sebbane2, Patrick Goudot1, Jacques Yachouh1
1Department of Plastic and Reconstructive Surgery, Lapeyronie University Hospital, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France
2Emergency Department, Lapeyronie University Hospital, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France

Tài liệu tham khảo

Tebble, 2006, Anxiety and self-consciousness in patients with facial lacerations one week and six month later, Br J Oral Maxillofac Surg, 44, 520, 10.1016/j.bjoms.2005.10.010 Langer K. On the anatomy and physiology of the skin: the cleavability of the cutis. Presented at the meeting of 26th April 1861. Gibson, 1978, Karl Langer and his lines, Br J Plast Surg, 3, 1, 10.1016/0007-1226(78)90002-4 Larrabee, 1995 McCarthy, 1990 Kocher, 1911 Gassner, 2006, Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study, Mayo Clin Proc, 8, 1023, 10.4065/81.8.1023 Sullivan, 2011, The level of evidence pyramid: indicating levels of evidence in plastic reconstructive surgery articles, Plast Reconstr Surg, 128, 311, 10.1097/PRS.0b013e3182195826 Fitzpatrick, 1975, Soleil et peau, J Med Esthet, 2, 33 Roques, 2007, A critical analysis of measurements used to assess and manage scars, Int J Low Extrem Wounds, 6, 249, 10.1177/1534734607308249 Quinn, 1998, Tissue adhesive versus suture wound repair at 1 year: randomized clinical trial correlating early, 3-month, and 1-year cosmetic outcome, Ann Emerg Med, 32, 645, 10.1016/S0196-0644(98)70061-7 Vercelli, 2009, How to assess postsurgical scars: a review of outcome measures, Disabil Rehabil, 31, 2055, 10.3109/09638280902874196 Nguyen, 2008, A review of current objective and subjective scar assessment tools, J Wound Care, 17, 101, 10.12968/jowc.2008.17.3.28666 Truong, 2007, Reliability and validity testing of the Patient and Observer Scar Assessment Scale in evaluating linear scars after breast cancer surgery, Plast Reconstr Surg, 119, 487, 10.1097/01.prs.0000252949.77525.bc Stavrou, 2009, Patient and observer scar assessment scale: how good is it?, J Wound Care, 18, 171, 10.12968/jowc.2009.18.4.41610 Duncan, 2006, Visual analogue scale scoring and ranking: a suitable and sensitive method for assessing scar quality?, Plast Reconstr Surg, 118, 909, 10.1097/01.prs.0000232378.88776.b0 Handschel, 2005, Objective assessment of cosmetic outcome of scars, Mund Kiefer Gesichtschir, 9, 396, 10.1007/s10006-005-0641-5 Wilson, 2006, Use of botulinum toxin type A to prevent widening of facial scars, Plast Reconstr Surg, 117, 1758, 10.1097/01.prs.0000209944.45949.d1 Choi, 1997, Use of botulinum A toxin in patients at risk of wound complications following eyelid reconstruction, Ophthal Plast Reconstr Surg, 13, 259, 10.1097/00002341-199712000-00006 Gassner, 2000, Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates, Plast Reconstr Surg, 105, 1948, 10.1097/00006534-200005000-00005 Sherris, 2002, Botulinum toxin to minimize facial scarring, Facial Plast Surg, 18, 35, 10.1055/s-2002-19825 Gassner, 2003, Chemoimmobilization: improving predictability in the treatment of facial scars, Plast Reconstr Surg, 112, 1464, 10.1097/01.PRS.0000081073.94689.DB Tollefson, 2006, Botulinum toxin to improve results in cleft lip repair, Arch Facial Plast Surg, 8, 221, 10.1001/archfaci.8.3.221